Disclosures for "Longitudinal Lymphocyte, CD3, and Neutrophil Counts as Predictive Biomarkers for Infection Risk Following Anti-CD20 Therapy in Patients With MS"
-
Ms. Dodson has nothing to disclose.
-
Dr. Jamal has nothing to disclose.
-
Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.